Searchable abstracts of presentations at key conferences in endocrinology

ea0005p5 | Bone | BES2003

Determination of a correlation between release of beta c-terminal telopeptides and area of resorption by recombinant rankl-generated human osteoclasts

Chan B , Buckley K , Dutton J , Gallagher J , Fraser W

The discovery of the fundamental involvement of receptor activator for nuclear factor-KB ligand (RANKL) in osteoclast (OC) formation, has enabled the routine generation of human OCs in vitro from human peripheral blood mononuclear cells (PBMCs). Beta C-terminal telopeptide (beta-CTx) is a specific resorption marker for degradation of bone type I collagen by OCs. We have evaluated the correlation between beta-CTx released from dentine wafers on which OC were c...

ea0004p77 | Reproduction | SFE2002

Metformin does not reduce the elevated C-reactive protein observed in obese women with PCOS

Fleming R , Hopkinson Z , Sattar N

C-reactive protein (CRP) is a marker of inflammatory processes which predicts vascular disease, and is raised in the circulation of women with PCOS. Metformin can be used to reduce insulin resistance in women with PCOS, leading to improved ovarian function and circulating lipid profiles. The aim of this study was to determine the effect of protracted metformin treatment on circulating CRP in women with PCOS.Methods: CRP was assessed in women with PCOS (n...

ea0003p297 | Thyroid | BES2002

Protein kinase C delta interacts with the sodium iodide symporter (NIS) to increase its activity in human thyrocytes

Turner F , Eggo M

Because the sodium iodide symporter, NIS, may be artificially expressed in cells to introduce ablative doses of radioactive iodide, it may be of clinical use. NIS is normally found in the basolateral membrane of thyrocytes and its expression and activity are known to be regulated by TSH. We have used primary cultures of human thyrocytes to examine other regulators of NIS activity. NIS activity was measured as uptake of 125I into cells in the presence of the thyroper...

ea0094p326 | Bone and Calcium | SFEBES2023

Two cases of familial hypocalciuric hypercalcaemia (FHH) due to a homozygous CaSR gene mutation (c.-10C>T)

Livingstone Rachel , Talla Maria

Familial hypocalciuric hypercalcaemia (FHH) is a rare autosomal dominant condition due to a mutation in the calcium-sensing receptor gene (CaSR). The CaSR is located on chromosome 3 and mutations are commonly heterozygote mutations causing loss of function. Heterozygote mutations demonstrate benign disease with mild, asymptomatic hypercalcaemia. Homozygous mutations in the CaSR usually present with neonatal severe hyperparathyroidism (NSHPT) in the first few weeks of life and ...

ea0090rc6.6 | Rapid Communications 6: Endocrine-related Cancer | ECE2023

C-peptide level concomitant with hypoglycemia gives better performances than insulin for the diagnosis of endogenous hyperinsulinism: a monocentric study of 159 fasting trials

Fideline Bonnet , Devin Clara , Thomeret Louis , Laguillier-Morizot Christelle , Leguy Marie-Clemence , Vaczlavik Anna , Bouys Lucas , Zientek Corinne , Bricaire Leopoldine , Bessiene Laura , Guignat Laurence , Libe Rossella , Mosnier-Pudar Helen , Assie Guillaume , Groussin Lionel , Guibourdenche Jean , Bertherat Jerome

Introduction: The gold standard for insulinoma diagnosis is still 72-hours fasting trial with the aim to trigger Whipple’s triad. In this context, biological diagnosis of endogenous hyperinsulinism relies on the occurrence of a hypoglycemia, concomitant with inadequate high insulin and C-peptide levels. However, diagnostic cut-offs are not consensual among the different learned societies (Endocrine Society 2009, NANETS 2010, ENETS 2012). The objective of this wor...

ea0020p410 | Diabetes and Cardiovascular | ECE2009

Metabolic syndrome and meal stimulated C-peptide levels as useful clinical markers in choosing metformin for combination therapy with sulphonylurea in type 2 diabetic subjects

Koprivica Branka , Zivkovic Teodora Beljic

Introduction: Monotherapy failure in diabetes mellitus type 2 occurs early in the course of disease. Evaluation of the primary pathogenetic mechanism is of primary importance in choosing the optimal combination therapy.Objectives: To investigate influence of meal stimulated C-peptide levels and HOMA B, as markers of residual insulin secretion on the efficasy of adding metformin to sulphonylurea therapy in subjects with metabolic syndrome, type 2 diabetes...

ea0031pl5 | British Thyroid Association Pitt-Rivers Lecture | SFEBES2013

BTA_Pitt Rivers Lecture

Bianco Antonio C

A C Bianco is a professor of medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Miami Miller School of Medicine. Dr A C Bianco obtained his MD, PhD and clinical training in internal medicine and endocrinology in Sao Paulo, Brazil. His work has established the importance of the local control of thyroid hormone activation/inactivation via deiodination, as well as fundamental cellular and molecular properties of the deiodinases (D1, ...

ea0063p607 | Diabetes, Obesity and Metabolism 2 | ECE2019

Liver fibrosis and steatosis severity evaluation in patients with chronic hepatitis C and type 2 diabetes mellitus

Irina Morozova , Beliy PA , Axelrod AG , Rodnikova EM , Dudina KR , Safiullina NH , Znoyko OO

Background: Non-alcoholic fatty liver disease and chronic hepatitis C (CHC) are systemic diseases with a broad spectrum of coexisting disorders, but their common features are insulin resistance and higher frequency of concomitant type 2 diabetes mellitus (DM). According to recent studies, a higher frequency of CHC in patients with DM is not associated with this cohort exposure to multiple medical interventions, but with CHC being a possible risk factor for developing DM. CHC m...

ea0041gp217 | Thyroid - Translational & Clinical (1) | ECE2016

Evaluation of the interrelations between thyroid function, insulin resistance, lipid profile, C-reactive protein and homocysteine in patients with autoimmune thyroiditis

Neves Celestino , Neves Joao Sergio , Oliveira Sofia Castro , Esteves Cesar , Sokhatska Oksana , Dias Camila , Delgado Luis , Medina Jose Luis , Carvalho Davide

Introduction: In patients with autoimmune thyroiditis, thyroid function appears to be related to increased cardiovascular risk. It was our objective to evaluate the relationship between TSH, insulin resistance, lipid profile, C-reactive protein (CRP) and homocysteine in patients with autoimmune thyroiditis (AIT).Methods: We analyzed the lipid profile, the CRP, anti-thyroid antibodies, homocysteine, folic acid, vitamin B12 levels and the insulin resistanc...

ea0029p216 | Calcium & Vitamin D metabolism | ICEECE2012

Serum cystatin C is a reliable predictor of renal function and cardiometabolic risk in primary hyperparathyroidism

Ermetici F. , Filopanti M. , Verga U. , Passeri E. , Zelaschi R. , Raggi M. , Beck-Peccoz P. , Spada A. , Corbetta S.

Primary hyperparathyroidism (PHPT) negatively affects renal function. It is known that chronic kidney disease is a predictor of cardiometabolic diseases. Cystatin C (cystC), an alternative measure of renal function, has been associated with adverse cardiovascular events and cardiometabolic risk factors. This study was aimed to evaluate serum cystC, its relationships with PTH and cardiometabolic risk in patients with PHPT.The following parameters were mea...